BioStem Technologies Takes Center Stage at SAWC Spring Meeting
BioStem Technologies, Inc. (OTC: BSEM) is preparing to make a significant impact at the upcoming Symposium for Advanced Wound Care (SAWC) Spring meeting, where it will proudly co-exhibit with its strategic partner Venture Medical, LLC. This collaboration underscores their joint commitment to innovation in chronic wound care management.
The SAWC is recognized as a leading platform for educating healthcare professionals focused on treating patients with chronic wounds. During this event, BioStem will not only highlight its proprietary BioREtain® technology but will also feature three scientific posters that affirm the efficacy of its advanced allograft portfolio.
Collaborative Innovation in Wound Care
By co-exhibiting with Venture Medical, BioStem aims to spotlight the combined strengths of its leading placental allograft alongside the Venture OneView™ platform. This state-of-the-art platform is designed to simplify the management of patients who require skin substitutes for chronic wound treatment. “Our premier products, AmnioWrap2® and Vendaje AC®, are primarily available through Venture Medical,” shared Jason Matuszewski, CEO of BioStem. “This partnership provides healthcare providers with tools to enhance patient care from insurance verification through treatment, ultimately streamlining the entire care process.”
SAWC Booth Schedule Overview
The BioStem and Venture Medical booth will feature designated times for attendees to interact with key industry stakeholders. Important discussions will include the emerging reimbursement landscape and building a successful mobile wound care practice. Also highlighted will be compelling data supporting the advantages of BioStem’s proprietary BioREtain® technology and how the Venture OneView™ platform benefits providers.
Highlighting Critical Topics
Friday's schedule includes a sponsored breakfast symposium titled Healing Under Pressure: Advancements in Skin Substitutes for Pressure Ulcer Treatment. This critical discussion will address the necessity of advanced wound care technologies in improving outcomes for patients with non-healing chronic wounds. Topics will cover the latest real-world clinical evidence, data collection efforts, practice management strategies, and legislative actions needed to enhance access to treatment.
Scientific Contributions and Insights
BioStem is excited to announce the display of three accepted scientific posters during the conference, each showcasing valuable clinical and scientific research regarding BioStem’s products. These include:
- Retrospective Analysis of Complicated Diabetic Foot Ulcers: A Comparison of Retention-Processed Placental Membranes and Standard of Care
- A Case Series for Managing Complicated Diabetic Foot Wounds
- Preservation of Key Molecular and Stromal Components via Retention Processing
The data presented in these posters aims to demonstrate the favorable outcomes achieved with BioStem’s BioREtain® technology compared to competitive products. Dr. Wendy Weston, Vice President of Research and Development at BioStem, remarked, “We’re committed to investing in evidence that supports the efficacy of our technology.”
About BioREtain® Technology
BioStem’s BioREtain® method is a proprietary processing technique that retains the essential properties of perinatal tissues while preserving the structure and matrix crucial for effective wound treatment. This patented process is gentle and minimally invasive, ensuring the integrity of amniotic tissue, which is vital for optimal healing outcomes.
Fundamentally, BioStem Technologies stands as a beacon of hope in wound care innovation. Each placental allograft is processed at their FDA registered and AATB accredited facility, embodying their commitment to quality and safety.
Connection and Collaboration
BioStem invites the healthcare community to join their distribution list and engage through their social media channels to stay updated on the latest developments. By fostering a community around wound care, BioStem aims to improve practices and outcomes for patients worldwide.
Frequently Asked Questions
What is the focus of BioStem Technologies?
BioStem Technologies specializes in developing placental-derived products for advanced wound care.
What is the BioREtain® technology?
BioREtain® is a proprietary processing method that preserves the natural properties of perinatal tissues for enhanced wound healing.
Where will the symposium take place?
The SAWC Spring meeting will be held in Dallas, Texas.
How can I learn more about BioStem products?
You can explore BioStem’s offerings by visiting their website or contacting their support team directly.
What partnership does BioStem have at the symposium?
BioStem is co-exhibiting with Venture Medical, emphasizing their collaborative efforts in wound care solutions.
